Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H10N2O3 |
| Molecular Weight | 146.1445 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CCC(O)=O)C(N)=O
InChI
InChIKey=AEFLONBTGZFSGQ-VKHMYHEASA-N
InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives. | 2003 Jan 2 |
|
| Synthesis of racemic cis-5-hydroxy-3-phthalimidoglutarimide. A metabolite of thalidomide isolated from human plasma. | 2005 Nov 25 |
|
| Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria. | 2009 Mar 27 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
636-65-7
Created by
admin on Sat Dec 16 08:20:31 GMT 2023 , Edited by admin on Sat Dec 16 08:20:31 GMT 2023
|
PRIMARY | |||
|
445883
Created by
admin on Sat Dec 16 08:20:31 GMT 2023 , Edited by admin on Sat Dec 16 08:20:31 GMT 2023
|
PRIMARY | |||
|
WL74QNU57B
Created by
admin on Sat Dec 16 08:20:31 GMT 2023 , Edited by admin on Sat Dec 16 08:20:31 GMT 2023
|
PRIMARY | |||
|
DB03091
Created by
admin on Sat Dec 16 08:20:31 GMT 2023 , Edited by admin on Sat Dec 16 08:20:31 GMT 2023
|
PRIMARY | |||
|
m6493
Created by
admin on Sat Dec 16 08:20:31 GMT 2023 , Edited by admin on Sat Dec 16 08:20:31 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD
